Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–10.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the global burden of disease study. Lancet. 2020;395(10219):200–11.

Article  PubMed  PubMed Central  Google Scholar 

Fleischmann C, Scherag A, Adhikari NKJ, Hartog CS, Tsaganos T, Schlattmann P, et al. Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. Am J Respir Crit Care Med. 2016;193(3):259–72.

Article  CAS  PubMed  Google Scholar 

Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med. 2008;36(3):941–52.

Article  CAS  PubMed  Google Scholar 

Antonelli M, Azoulay E, Bonten M, Chastre J, Citerio G, Conti G, et al. Year in review in Intensive Care Medicine 2010: II. Pneumonia and infections, cardiovascular and haemodynamics, organization, education, haematology, nutrition, ethics and miscellanea. Intensive Care Med. 2011;37(2):196–213.

Article  PubMed  PubMed Central  Google Scholar 

Schuetz P, Christ-Crain M, Müller B. Procalcitonin and other biomarkers to improve assessment and antibiotic stewardship in infections—hope for hype? Swiss Med Wkly. 2009;139(23–24):318–26.

CAS  PubMed  Google Scholar 

Pierrakos C, Velissaris D, Bisdorff M, Marshall JC, Vincent J-L. Biomarkers of sepsis: time for a reappraisal. Crit Care. 2020;24(1).

Watts D, Gaete D, Rodriguez D, Hoogewijs D, Rauner M, Sormendi S, et al. Hypoxia pathway proteins are master regulators of erythropoiesis. Int J Mol Sci. 2020;21(21):8131.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fisher JW, Birdwell BJ. The production of an erythropoietic factor by the in situ perfused kidney. Acta Haematol. 1961;26:224–32.

Article  CAS  PubMed  Google Scholar 

Dame C, Fahnenstich H, Freitag P, Hofmann D, Abdul-Nour T, Bartmann P, et al. Erythropoietin mRNA expression in human fetal and neonatal tissue. Blood. 1998;92(9):3218–25.

Article  CAS  PubMed  Google Scholar 

Tóthová Z, Tomc J, Debeljak N, Solár P. STAT5 as a key protein of erythropoietin signalization. Int J Mol Sci. 2021;22(13):7109.

Article  PubMed  PubMed Central  Google Scholar 

Habib P, Stamm AS, Zeyen T, Noristani R, Slowik A, Beyer C, et al. EPO regulates neuroprotective transmembrane BAX inhibitor-1 motif-containing (TMBIM) family members GRINA and FAIM2 after cerebral ischemia-reperfusion injury. Exp Neurol. 2019;320:112978.

Article  CAS  PubMed  Google Scholar 

Tan R, Tian H, Yang B, Zhang B, Dai C, Han Z, et al. Autophagy and Akt in the protective effect of erythropoietin helix B surface peptide against hepatic ischaemia/reperfusion injury in mice. Sci Rep. 2018;8(1):14703.

Article  PubMed  PubMed Central  Google Scholar 

Brines M, Cerami A. Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response. J Intern Med. 2008;264(5):405–32.

Article  CAS  PubMed  Google Scholar 

Suresh S, Rajvanshi PK, Noguchi CT. The many facets of erythropoietin physiologic and metabolic response. Front Physiol. 2019;10:1534.

Article  PubMed  Google Scholar 

Cantarelli C, Angeletti A, Cravedi P. Erythropoietin, a multifaceted protein with innate and adaptive immune modulatory activity. Am J Transplant. 2019;19(9):2407–14.

Article  PubMed  PubMed Central  Google Scholar 

Teoh J, Boulos S, Chieng J, Knuckey NW, Meloni BP. Erythropoietin increases neuronal NDPKA expression, and NDPKA up-regulation as well as exogenous application protects cortical neurons from in vitro ischemia-related insults. Cell Mol Neurobiol. 2014;34(3):379–92.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arcasoy MO. The non-haematopoietic biological effects of erythropoietin. Br J Haematol. 2008;141(1):14–31.

Article  CAS  PubMed  Google Scholar 

Jelkmann W. Regulation of erythropoietin production. J Physiol. 2011;589(Pt 6):1251–8.

Article  CAS  PubMed  Google Scholar 

Wagner M, Alam A, Zimmermann J, Rauh K, Koljaja-Batzner A, Raff U, et al. Endogenous erythropoietin and the association with inflammation and mortality in diabetic chronic kidney disease. Clin J Am Soc Nephrol. 2011;6(7):1573–9.

Article  CAS  PubMed  Google Scholar 

Molnar MZ, Tabak AG, Alam A, Czira ME, Rudas A, Ujszaszi A, et al. Serum erythropoietin level and mortality in kidney transplant recipients. Clin J Am Soc Nephrol. 2011;6(12):2879–86.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Belonje AM, Voors AA, van der Meer P, van Gilst WH, Jaarsma T, van Veldhuisen DJ. Endogenous erythropoietin and outcome in heart failure. Circulation. 2010;121(2):245–51.

Article  CAS  PubMed  Google Scholar 

Tamion F, Le Cam-Duchez V, Menard JF, Girault C, Coquerel A, Bonmarchand G. Serum erythropoietin levels in septic shock. Anaesth Intensive Care. 2005;33(5):578–84.

Article  CAS  PubMed  Google Scholar 

Jiang Y, Jiang FQ, Kong F, An MM, Jin BB, Cao D, et al. Inflammatory anemia-associated parameters are related to 28-day mortality in patients with sepsis admitted to the ICU: a preliminary observational study. Ann Intensive Care. 2019;9(1):67.

Article  PubMed  PubMed Central  Google Scholar 

Stevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825–30.

Article  PubMed  Google Scholar 

Agusti A, Celli BR, Criner GJ, Halpin D, Anzueto A, Barnes P, et al. Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary. Am J Respir Crit Care Med. 2023;207(7):819–37.

Article  CAS  PubMed  PubMed Central  Google Scholar 

White PD, Myers M. The classification of cardiac diagnosis. JAMA. 1921;77(18):1414–5.

Article  Google Scholar 

Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. Hoboken: Wiley; 2011.

Google Scholar 

Li W, Wang M, Zhu B, Zhu Y, Xi X. Prediction of median survival time in sepsis patients by the SOFA score combined with different predictors. Burns Trauma. 2020;8:tkz006.

Abel J, Spannbrucker N, Fandrey J, Jelkmann W. Serum erythropoietin levels in patients with sepsis and septic shock. Eur J Haematol. 1996;57(5):359–63.

Article  CAS  PubMed  Google Scholar 

Tamion F, Le Cam-Duchez V, Menard JF, Girault C, Coquerel A, Bonmarchand G. Erythropoietin and renin as biological markers in critically ill patients. Crit Care. 2004;8(5):R328–35.

Article  PubMed  PubMed Central  Google Scholar 

Jelkmann W. Erythropoietin: structure, control of production, and function. Physiol Rev. 1992;72(2):449–89.

Article  CAS  PubMed  Google Scholar 

Heitrich M, Garcia DM, Stoyanoff TR, Rodriguez JP, Todaro JS, Aguirre MV. Erythropoietin attenuates renal and pulmonary injury in polymicrobial induced-sepsis through EPO-R, VEGF and VEGF-R2 modulation. Biomed Pharmacother. 2016;82:606–13.

Article  CAS